Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands

AIDS Research and Human Retroviruses

Volumn 27, Issue 4, 2011, Pages 429-433

  Van Der Kuyl, Antoinette C ^a   Jurriaans, Suzanne ^a   Back, Nicole K T ^a   Sprenger, Herman G ^b   Van Der Werf, Tjip S ^b   Zorgdrager, Fokla ^a   Berkhout, Ben ^a   Cornelissen, Marion ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; SEDATIVE AGENT; VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD DONOR; CRIMINAL BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MEDICAL RECORD; MIXED INFECTION; NETHERLANDS; PRIORITY JOURNAL; RECIPIENT; SEXUAL ABUSE; VIRUS STRAIN;

CLUSTER ANALYSIS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; NETHERLANDS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 79953751658     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0175     Document Type: Article

References (13)

1. Jost S, Bernard MC, Kaiser L, et al.: A patient with HIV-1 superinfection. N Engl J Med 2002;347(10):731-736. (Pubitemid 35203904)
2. van der Kuyl AC and Cornelissen M: Identifying HIV-1 dual infections. Retrovirology 2007;4(1):67.
3. Gonzales MJ, Delwart E, Rhee SY, et al.: Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J Infect Dis 2003;188(3): 397-405. (Pubitemid 36960650)
4. Tsui R, Herring BL, Barbour JD, et al.: Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. J Virol 2004;78(1):94-103. (Pubitemid 37549722)
5. van der Kuyl AC, Zorgdrager F, Jurriaans S, et al.: Incidence of human immunodeficiency virus type 1 dual infections in Amsterdam, The Netherlands, during 2003-2007. Clin Infect Dis 2009;48(7):973-978.
6. Boom R, Sol CJ, Salimans MM, et al.: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28(3):495-503. (Pubitemid 20078123)
7. Delwart EL, Herring B, Rodrigo AG, and Mullins JI: Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl 1995;4(5):S202-S216.
8. Kozaczynska K, Cornelissen M, Reiss P, Zorgdrager F, and van der Kuyl AC: HIV-1 sequence evolution in vivo after superinfection with three viral strains. Retrovirology 2007;4(1):59.
9. Cornelissen M, Jurriaans S, Kozaczynska K, et al.: Routine HIV-1 genotyping as a tool to identify dual infections. AIDS 2007;21(7):807-811. (Pubitemid 46573152)
10. Piantadosi A, Ngayo MO, Chohan B, and Overbaugh J: Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 2008;24(9):1221.
11. Salazar-Gonzalez JF, Bailes E, Pham KT, et al.: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 2008;82(8):3952-3970. (Pubitemid 351521232)
12. Abrahams MR, Anderson JA, Giorgi EE, et al.: Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 2009;83(8):3556-3567.
13. Bar KJ, Li H, Chamberland A, et al.: Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 2010;84(62):6241-6247.